An overiew of CAR-T cell therapy - Dr Sridhar Chaganti
Release Date: 02/10/2020
Dr Mark Bishton on Haemophagocytic Lymphohistiocytosis (HLH)
blooducation's podcast
Helen chats to Dr Mark Bishton on Haemophagocytic Lymphohistiocytosis (HLH)
info_outline
Fetal and neonatal alloimmune thrombocytopenia with Elina Vlachodimitropoulou and Mike Desborough
blooducation's podcast
Suzy talks to Elina Vlachodimitropoulou, consultant obstetrician, and Mike Desborough, consultant haematologist, about FNAIT
info_outline
CLL management with Dr Renata Walewska
blooducation's podcast
Helen talsk to Dr Renata Walewska about CLL management
info_outline
Polycythemia with Dr Hayder Hussein
blooducation's podcast
Suzy and Hayder discuss the investigation of patients with high haemotocrtis and delve into treatment aspects of primary and secondary polycythemia
info_outline
Common immunological scenarios we encounter in haematology and how we manage them
blooducation's podcast
Helen discusses Common immunological scenarios we encounter in haematology and how we manage them with Dr Adrian Shields
info_outline
Blood shortages and major incident planning
blooducation's podcast
Helen and Suzy discuss blood shortages and major incident planning
info_outline
Major haemorrhage - Dr Laura Green
blooducation's podcast
Suzy talks to Laura Green about the practical aspects of major haemorrhage and the evidence underpinning practice. Links
info_outline
Hairy Cell Leukaemia and reclassifying Variant HCL - Dr Nilima Parry-Jones and Dr Anurag Joshi
blooducation's podcast
This week we discuss Hairy Cell Leukaemia and reclassifying Variant HCL with Dr Nilima Parry-Jones and Dr Anurag Joshi
info_outline
Autoimmune haemolytic anaemia - Dr Quentin Hil
blooducation's podcast
Suzy speaks to Quentin Hill about pitfalls in diagnosis and treatment of haemolytic anaemia.
info_outline
Special components in transfusion - Dr Suzy Morton
blooducation's podcast
Helen talks to Suzy Morton about different blood components and when they are indicated Links:
info_outlineWe are just at the start of what many are calling “the CAR-T cell revolution”. But what are CAR-T cells, how are they made, who can receive them and what are the draw-backs? Dr Sridhar Chaganti talks to Suzy Morton about haematology’s latest breakthrough.